Health Equity in Clinical Trials New Jersey Participant Demographics

Webinar: Health Equity in Clinical Trials
New Hersey Participant Demographics

Thursday, November 7, 2024 | 12:00 p.m.-1:00 p.m.

Be among the first to hear the findings in BioNJ’s newly published whitepaper, “Health Equity in Clinical Trials: New Jersey Participant Demographics,” presented in partnership with Medidata, a Dassault Systèmes brand and the leading provider of clinical trial solutions to the life sciences industry.

Clinical trials represent a $15.2 billion industry in the U.S., with a continuing need for increased participation.

Therefore, this pioneering research tackles a critical goal: supporting the recruitment of underrepresented communities in clinical trials, specifically in New Jersey, while comparing New Jersey’s recruitment performance with similar states, such as Connecticut, Maryland, Massachusetts and New York.

Join us on November 7 as our experts share key findings, shed light on demographic recruitment variations across states and define crucial public policy opportunities to pursue more accurate demographic representation according to epidemiological data.

By attending, you’ll gain insights to help ensure that clinical trials more accurately reflect and serve the diverse populations they aim to benefit. Click here to register for free.

Hear from:

Click here to download a copy of “Health Equity in Clinical Trials: New Jersey Participant Demographics“.